These 3 Small-Cap Healthcare Stocks Reported Big Updates This Month
Axsome Therapeutics, Flexion Therapeutics, and UroGen Pharma gave investors reasons for excitement.
Flexion Therapeutics
FLXN
FLXN
$10.94
-$0.34
0.0%
BATS BZX Real Time Price as of June 14, 2019, 3:38 p.m.
View Interactive FLXN Charts
FLEXION THERAPEUTI
News & Analysis: Flexion Therapeutics
Flexion Therapeutics, Inc. (FLXN) Q1 2019 Earnings Call Transcript
FLXN earnings call for the period ending March 31, 2019.
Here's Why Flexion Therapeutics Jumped as Much as 18.4% Today
The pharma company announced first-quarter 2019 operating results.
Flexion Therapeutics Inc (FLXN) Q4 2018 Earnings Conference Call Transcript
FLXN earnings call for the period ending December 31, 2018.
Here's Why Flexion Therapeutics Rose 29.8% in January
The company reported preliminary full-year 2018 results and set expectations for a solid year of growth in 2019.
Here's Why Flexion Therapeutics Jumped 20.5% in November
The small-cap biopharma announced third-quarter 2018 operating results and a business update.
Why Flexion Therapeutics Jumped 12.6% Today
There was good news on the payer front.
2018 Is a Critical Year for These 3 Small Commercial-Stage Biotech Stocks
It could be a make-it-or-break-it kind of year for these up-and-coming biotech companies.
This Small-Cap Biotech Stock Is Onto Something Big
A newly approved drug that could shake up how doctors treat knee pain could be very profit-friendly for investors.
A New FDA Approval Sends Small Cap Flexion Soaring
Flexion's non-opioid pain management drug has huge potential, and it's looking to expand into more indications.
